In a report released today, Matt Hewitt from Craig-Hallum assigned a Buy rating to MaxCyte (MXCT – Research Report). The company’s shares ...

All three Cache Exchange Funds, which are benchmarked to te Nasdaq-100® Index, delivered noteworthy outperformance relative to the benchmark, exceeding it anywhere from 7.9% to 10.7%, as these ...

Neuronoff, Inc., a pioneer in minimally invasive neuromodulation solutions, today announced two major funding milestones totaling $5 million to advance its innovative Injectrode® technology. The ...